If the cells you would like to access are currently listed as unavailable
or you are ordering from outside of Europe please get in touch via
Contact@EBiSC.org.
WTSIi105-B
HPSI0313i-airc_66
iPSC line
The cell line was withdrawn.
General#
Cell Line |
|
hPSCreg name | WTSIi105-B |
Alternative name(s) |
HPSI0313i-airc_66
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines | No similar lines found. |
Provider |
|
Depositor | Wellcome Sanger Institute (WTSI) |
Distributors |
EBiSC
|
Derivation country | United Kingdom |
External Databases |
|
hPSCreg | WTSIi105-B |
BioSamples | SAMEA2399089 |
HipSci | HPSI0313i-airc_66 |
Cellosaurus | CVCL_AE70 |
Wikidata | Q54890599 |
General Information |
|
Publications | View all related publications on hPSCreg (1) |
This EBiSC line can be used for: |
Yes
Research use: allowed
Clinical use: no
Commercial use: no
|
Donor Information#
General Donor Information |
|
Sex | female |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
Donor Relations |
|
Other cell lines of this donor |
|
External Databases (Donor) |
|
BioSamples | SAMEA2398654 |
HipSci | HPSI-airc |
hIPSC Derivation#
General |
|
Source cell type |
A connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. Flattened and irregular in outline with branching processes; appear fusiform or spindle-shaped.; These cells may be vimentin-positive, fibronectin-positive, fsp1-positive, MMP-1-positive, collagen I-positive, collagen III-positive, and alpha-SMA-negative.
|
Source cell origin |
Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis.
Synonyms
|
Source cell line vendor | Cambridge BioResource |
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Genes | |
Notes on reprogramming vector detection | CytoTune 1 |
Vector free reprogramming |
|
Other |
|
Selection criteria for clones | Morphology |
Derived under xeno-free conditions |
No |
Derived under GMP? |
No |
Available as clinical grade? |
No |
Culture Conditions#
The following are the depositor culture conditions, they do not refer to any specific batch.
Surface coating | Vitronectin |
Feeder cells |
No |
Passage method |
Enzyme-free cell dissociation
EDTA
|
CO2 Concentration | 5 % |
Medium |
TeSR™ E8™
|
Characterisation#
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
POU5F1 (OCT-4) |
Yes |
|
||||
SOX2 |
Yes |
|
||||
NANOG |
Yes |
|
Pluripotency Score | Novelty Score | Link to microarray data |
36.475 | 1.523 | https://www.ebi.ac.uk/ega/datasets/EGAD00010000775 |
Report
HPSI-airc.pluritest.pluripotency_score.20161010.png
pluripotency image
HPSI-airc.pluritest.novelty_score.20161010.png
novelty image
Genotyping#
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
No
|
Other Genotyping (Cell Line) |
|
Is there genome-wide genotyping or functional data available? |
Yes
Exome sequencing
https://www.ebi.ac.uk/ega/studies/EGAS00001000592
cnv
http://www.hipsci.org/lines/#/lines/HPSI0313i-airc_66 Number of regions different from primary tissue: 4; Length of differences from primary tissue: 3 |